NCT03764072View on ClinicalTrials.gov

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

PHASE2CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

January 17, 2019

Study Completion Date

January 25, 2019

Conditions

Acute Pain

Interventions

DRUG

VX-150

Capsules for oral administration.

DRUG

Placebo

Capsules for oral administration.

Trial Locations (6)

21122

Chesapeake Research Group, Pasadena

78229

Endeavor Clinical Trials, San Antonio

84107

JBR Clinical Research, Salt Lake City

85053

Arizona Research Center, Phoenix

91105

Lotus Clinical Research, Pasadena

92801

Anaheim Clinical Trials, Anaheim

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT03764072 - A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy | Biotech Hunter | Biotech Hunter